Abstract
Marijuana is among the most widely used of the drugs described in this text. The health-care problems involved with delta-9-tetrahydrocannabinol (THC) (the most active ingredient in marijuana and hashish), include panic reactions, toxic reactions, and a great deal of anxiety in the general population about possible mental and physiological damage to young users. Because you will be called on, as a healthcare deliverer, to give information about this drug to worried parents and to teenagers attempting to make decisions about future use, this chapter presents information on the history, the physiology, and the medical effects of the cannabinols.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Weller, R. A., und Halikas, J. A. Objective criteria for the diagnosis of marijuana abuse. Journal of Nervous and Mental Disease 168: 98–103, 1980.
Jaffe, J. H. Drug addiction and drug abuse. In A. G. Gilman, L. S. Goodman, und A. Gilman (Eds.), The Pharmacological Basis of Therapeutics ( 7th ed. ). New York: Macmillan, 1985, pp. 558–561.
Liskow, B. Marijuana deterioration. Journal of the American Medical Association 214:1709, 1970.
Talbott, J. A. The emergency management of marijuana psychosis. In P. G. Bourne (Ed.), A Treatment Manual for Acute Drug Abuse Emergencies. Washington, D.C.: U.S. Govemment Printing Office, 1974, pp. 83–87.
Domino, L. E., Domino, S. E., und Domino, E. F. Do plasma levels of delta-9-tetrahydrocannabinol reflect a marijuana high? Psychopharmacology Bulletin 19: 760–765, 1983.
Sallan, S. E. Antiemetics in patients receiving chemotherapy for cancer. New England Journal of Medicine 302: 135–138, 1980.
Harris, L. S. Cannabinoids as analgesics. In R. F. Beers und T. Basset (Eds.), Pain and Analgesic Compounds. New York: Raven Press, 1979, pp. 467–473.
Nahas, G. Biomedical aspects of cannabis usage. Bulletin on Narcotics 24: 13–27, 1977.
Dackis, C. A., Pottash, A. L. C., Annito, W., Persistence of urinary marijuana levels after supervised abstinence. American Journal of Psychiatry 139:1196–1198, 1982.
Sethi, B. G. B., Trivedi, J. K., Kumar, P., et al. Antianxiety effect of cannabis: Involvement of central benzodiazepine receptors. Biological Psychiatry 21: 3–10, 1986.
Stillman, R., Galanter, M., und Lemberger, L. Tetrahydrocannabinol (THC): Metabolism and subjective effects. Life Sciences 19: 569–576, 1976.
Mendelson, J. H., Rossi, A. M., und Meyer, R. E. The Use of Marihuana: A Psychological and Physiological Inquiry. New York: Plenum Press, 1974.
Galanter, M., Stillman, R., Wyatt, R. J., Marihuana and social behavior: A controlled study. Archives of General Psychiatry 30: 518–521, 1974.
Weil, A. T., Zinberg, N. E., und Nelsen, J. M. Clinical and psychological effects of marihuana in man. Science 162:1234–1242, 1968.
Weil, A. T. Adverse reactions to marihuana: Classification and suggested treatment. New England Journal of Medicine 282: 997–1000, 1970.
Feeney, D. M. Marihuana and epilepsy. Science 197: 1301–1302, 1977.
Nicholi, A. M. The nontherapeutic use of psychoactive drugs. New England Journal of Medicine 308: 925–933, 1983.
Cohen, S., Sc Stillman, R. C. The Therapeutic Potential of Marihuana. New York: Plenum Press, 1976.
Gottschalk, L. A. Aronow, W. S., und Prakash, R. Effect of marijuana and placebo-marijuana smoking on psychological state and on psychophysiological cardiovascular functioning in anginal patients. Biological Psychiatry 12: 255–266, 1977.
Jones, R. T. Clinical relevance of cannabis tolerance and dependence. Journal of Clinical Pharmacology 211: 1435–1475, 1981.
Perez-Reyes, M., Hicks, R., Bumberry, J., Jeffcoat, A. R., und Coak, C. E. Interaction between marijuana and alcohol. Alcoholism: Clinical and Experimental Research 12: 268–272, 1988.
Kaymakcalan, S. Potential dangers of cannabis. International Journal of the Addictions 10: 72 1735, 1975.
Smart, R. G., und Murray, G. F. A review of trends in alcohol and cannabis use among young people. Bulletin on Narcotics 33: 77–90, 1981.
Wechsler, H., und Rohman, M. E. Patterns of drug use among New England college students. American Journal of Drug and Alcohol Abuse 8: 27–37, 1981.
Reiman, A. S. Marijuana “justifies serious concern.” In Marijuana and Health Washington, D.C.: National Academy Press, 1982.
Kozel, N. J., und Adams, E. H. Epidemiology of drug abuse: An overview. Science 234: 970–974, 1986.
Smart, R. G., Adlaf, E. M., und Goodstadt, M. S. Alcohol and other drug use among Ontario students: An update. Canadian Journal of Public Health 77: 57–58, 1986.
Smart, R. G., Goodstadt, M. S., Adlaf, E. M., Trends in the prevalence of alcohol and other drug use among Ontario students: 1977–1983. Canadian Journal of Public Health 76: 157–161, 1985.
Editorial: National survey finds continuing decline in use of illicit drugs by high school seniors. Hospital and Community Psychiatry 36: 1011–1012, 1985.
Editorial: Epidemiology of drug usage. Lancet 1: 147, 1985.
Kandel, D. B. Marijuana users in young adulthood. Archives of General Psychiatry 41: 200–209, 1984.
Lex, B. W., Griffin, M. L., Mello, N. K., und Mendelson, J. H. Concordant alcohol and marihuana use in women. Alcohol 3: 193–200, 1986.
Kandel, D. B., Davies, M., Karus, D., und Yamaguchi, K. The consequences in young adulthood of adolescent drug involvement. Archives of General Psychiatry 43: 746–754, 1986.
Rose, M. Cannabis: A medical question? Lancet 1: 703, 1980.
Halikas, J. A., Goodwin, D. W., und Guze, S. B. Marihuana use and psychiatric illness. Archives of General Psychiatry 27:162–165, 1972.
Treffert, D. A. Marihuana use in schizophrenia: A clear hazard. Paper presented at the 130th Annual Meeting of the American Psychiatric Association, Toronto, Ontario, Canada, May 5, 1977.
Edwards, G. Psychopathology of a drug experience. British Journal of Psychiatry 143: 509–512, 1983.
Smart, R. G., und Adlaf, E. M. Adverse reactions and seeking medical treatment among student cannabis users. Drug and Alcohol Dependence 9: 201–211, 1982.
Miszzek, K. A. Behavioral effects of chronic marijuana. Psychopharmacology 67:195–201, 1980.
Weller, R. A., und Halikas, J. A. Marijuana use and psychiatric illness: A follow-up study. American Journal of Psychiatry 142: 848–850, 1985.
Andreasson, S., Allebeck, P., Engstrom, A., und Rydberg, U. Cannabis and schizophrenia: A longitudinal study of Swedish conscripts. Lancet 2:1483–1484, 1987.
Szmanzki, H. V. Prolonged depersonalization after marijuana use. American Journal of Psychiatry 138: 231–233, 1981.
Schaeffer, J. Cognition and long-term use of ganja. Science 13: 465, 1981.
Brill, N. Q., und Christie, R. L. Marihuana use and psychosocial adaptation. Follow-up study of a collegiate population. Archives of General Psychiatry 31:713–719, 1974.
Goodwin, D. W., und Guze, S. B. Psychiatric Diagnosis ( 4th ed. ). New York: Oxford University Press, 1988.
Meyer, R. E. Psychiatric consequences of marijuana use. In J. R. Tinklenberg (Ed.), Marijuana and Health Hazards. New York: Academic Press, 1975, pp. 133–152.
Spector, I. AMP: A new form of marijuana. Journal of Clinical Psychiatry 46: 498–499, 1985.
Campbell, A. M. G., Evans, M., Thomason, J. L. G., Cerebral atrophy in young cannabis smokers. Lancet 2:1219–1224, 1974.
Grant, I., und Mohns, L. Chronic cerebral effects of alcohol and drug abuse. International Journal of the Addictions 10: 883–920, 1975.
Stefanis, C., Laikos, A., Boulougouris, J., et al. Chronic hashish use and mental disorder. American Journal of Psychiatry 13: 225–227, 1976.
Wu, T. C., Tashkin, D. P., Djahed, B., und Rose, J. E. Pulmonary hazards of smoking marijuana as compared with tobacco. New England Journal of Medicine 318: 347–351, 1988.
Taylor, D. N., Washsmuth, I. K., Shangkuan, Y. H., Salmonellosis associated with marijuana: A multistate outbreak traced by pasmid fingerprinting. New England Journal of Medicine 306:1249–1253, 1982.
Dalterio, S., Badr, F., Bartke, A., Cannabinoids in male mice: Effects on fertility and spermatogenesis. Science 216:315–316, 1982.
Clapp, J. F., Wesley, M., Cooke, R., The effects of marijuana smoke on gas exchange in ovine pregnancy. Alcohol and Drug Research 7: 85–92, 1986.
Smith, C. G., und Asch, R. H. Drug abuse and reproduction. Fertility and Sterility 48: 355–373, 1987.
Mendelson, J. H., Ellingboe, J., und Mello, N. K. Acute effects of natural and synthetic cannabis compounds on prolactin levels in human males. Pharmacology, Biochemistry and Behavior 20:103-106, 1984.
Heath, R. G. Cannabis: Effects on brain function and ultrastructure. Biological Psychiatry 15:657-690, 1980.
Bier, M. M., und Steahly, L. P. Emergency treatment of marihuana complicating diabetes. In P. G. Boume (Ed.), A Treatment Manual for Acute Drug Abuse Emergencies. Washington, D.C.: U.S. Government Printing Office, 1974, pp. 88–94.
Fortenberry, J. C., Brown, D. B., und Shevlin, L. T. Analysis of drug involvement in traffic fatalities in Alabama. American Journal of Drug and Alcohol Abuse 12: 257–267, 1986.
Yesavage, J. A., Leiner, V. O., Denari, M., und Hollister, L. E. Carryover effects of marijuana intoxication on aircraft pilot performance: A preliminary report. American Journal of Psychiatry 142:1325–1329, 1985.
Sutton, L. The effects of alcohol, marihuana and their combination on driving ability. Journal of Studies on Alcohol 44: 438–445, 1983.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer Science+Business Media New York
About this chapter
Cite this chapter
Schuckit, M.A. (1989). Cannabinols. In: Drug and Alcohol Abuse. Critical Issues in Psychiatry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0767-0_7
Download citation
DOI: https://doi.org/10.1007/978-1-4757-0767-0_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-0769-4
Online ISBN: 978-1-4757-0767-0
eBook Packages: Springer Book Archive